Microbix Biosystems, Inc. v. Novartis Vaccines and Diagnostics, Inc., No. 6:14-cv-00003 (E.D. Tex. Feb. 17, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This opinion construes United States Patent No. 7,270,990 (the “’990 patent”). Plaintiff Microbix Biosystems, Inc. (“Microbix”) filed an Opening Claim Construction Brief (Doc. No. 68). Defendant Novartis Vaccines and Diagnostics, Inc. (“Novartis”) filed a Responsive Claim Construction Brief (Doc. No. 70). Microbix filed a Reply Brief (Doc. No. 72). Additionally, the parties submitted a Joint Claim Construction Chart . A Markman hearing was held on January 15, 2015.